Chronic Heart Failure- AMGEN 20110203
The purpose of this study is to reduce the risk of cardiovascular death or heart failure in patients with reduced ejection fraction (GALACTIC-HF).
Indication: Heart Failure
Age: ≥ 18 to ≤ 85 years of age
For more information: https://clinicaltrials.gov/ct2/show/NCT02929329
Studies Currently Available At
- North Vancouver View Location